86 related articles for article (PubMed ID: 27575941)
1. Gain-of-function Prolactin Receptor Variants Are Not Associated With Breast Cancer and Multiple Fibroadenoma Risk.
Chakhtoura Z; Laki F; Bernadet M; Cherifi I; Chiche A; Pigat N; Bernichtein S; Courtillot C; Boutillon F; Bièche I; Vacher S; Tanguy ML; Bissery A; Grouthier V; Camparo P; Foretz M; Do Cruzeiro M; Pierre R; Rakotozafy F; Tichet J; Tejedor I; Guidotti JE; Sigal-Zafrani B; Goffin V; Touraine P
J Clin Endocrinol Metab; 2016 Nov; 101(11):4449-4460. PubMed ID: 27575941
[TBL] [Abstract][Full Text] [Related]
2. Characterization of two constitutively active prolactin receptor variants in a cohort of 95 women with multiple breast fibroadenomas.
Courtillot C; Chakhtoura Z; Bogorad R; Genestie C; Bernichtein S; Badachi Y; Janaud G; Akakpo JP; Bachelot A; Kuttenn F; Goffin V; Touraine P;
J Clin Endocrinol Metab; 2010 Jan; 95(1):271-9. PubMed ID: 19897676
[TBL] [Abstract][Full Text] [Related]
3. Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.
Bogorad RL; Courtillot C; Mestayer C; Bernichtein S; Harutyunyan L; Jomain JB; Bachelot A; Kuttenn F; Kelly PA; Goffin V; Touraine P;
Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14533-8. PubMed ID: 18779591
[TBL] [Abstract][Full Text] [Related]
4. Germline Prolactin Receptor Mutation Is Not a Major Cause of Sporadic Prolactinoma in Humans.
Bernard V; Bouilly J; Beau I; Broutin I; Chanson P; Young J; Binart N
Neuroendocrinology; 2016; 103(6):738-45. PubMed ID: 26641246
[TBL] [Abstract][Full Text] [Related]
5. Association of prolactin and its receptor gene regions with familial breast cancer.
Vaclavicek A; Hemminki K; Bartram CR; Wagner K; Wappenschmidt B; Meindl A; Schmutzler RK; Klaes R; Untch M; Burwinkel B; Försti A
J Clin Endocrinol Metab; 2006 Apr; 91(4):1513-9. PubMed ID: 16434456
[TBL] [Abstract][Full Text] [Related]
6. Long-term risk of breast cancer in women with fibroadenoma.
Dupont WD; Page DL; Parl FF; Vnencak-Jones CL; Plummer WD; Rados MS; Schuyler PA
N Engl J Med; 1994 Jul; 331(1):10-5. PubMed ID: 8202095
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues.
Touraine P; Martini JF; Zafrani B; Durand JC; Labaille F; Malet C; Nicolas A; Trivin C; Postel-Vinay MC; Kuttenn F; Kelly PA
J Clin Endocrinol Metab; 1998 Feb; 83(2):667-74. PubMed ID: 9467590
[TBL] [Abstract][Full Text] [Related]
8. Re-evaluation of the prolactin receptor expression in human breast cancer.
Galsgaard ED; Rasmussen BB; Folkesson CG; Rasmussen LM; Berchtold MW; Christensen L; Panina S
J Endocrinol; 2009 Apr; 201(1):115-28. PubMed ID: 19153125
[TBL] [Abstract][Full Text] [Related]
9. A Neutralizing Prolactin Receptor Antibody Whose In Vivo Application Mimics the Phenotype of Female Prolactin Receptor-Deficient Mice.
Otto C; Särnefält A; Ljungars A; Wolf S; Rohde-Schulz B; Fuchs I; Schkoldow J; Mattsson M; Vonk R; Harrenga A; Freiberg C
Endocrinology; 2015 Nov; 156(11):4365-73. PubMed ID: 26284426
[TBL] [Abstract][Full Text] [Related]
10. A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice.
Binart N; Imbert-Bollore P; Baran N; Viglietta C; Kelly PA
Mol Endocrinol; 2003 Jun; 17(6):1066-74. PubMed ID: 12624115
[TBL] [Abstract][Full Text] [Related]
11. Identification of gain-of-function variants of the human prolactin receptor.
Goffin V; Bogorad RL; Touraine P
Methods Enzymol; 2010; 484():329-55. PubMed ID: 21036240
[TBL] [Abstract][Full Text] [Related]
12. Identification of prolactin receptor variants with diverse effects on receptor signalling.
Gorvin CM; Newey PJ; Thakker RV
J Mol Endocrinol; 2023 Apr; 70(3):. PubMed ID: 36445946
[TBL] [Abstract][Full Text] [Related]
13. Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.
Spoerri M; Guscetti F; Hartnack S; Boos A; Oei C; Balogh O; Nowaczyk RM; Michel E; Reichler IM; Kowalewski MP
BMC Vet Res; 2015 Sep; 11():235. PubMed ID: 26370564
[TBL] [Abstract][Full Text] [Related]
14. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.
Wennbo H; Gebre-Medhin M; Gritli-Linde A; Ohlsson C; Isaksson OG; Törnell J
J Clin Invest; 1997 Dec; 100(11):2744-51. PubMed ID: 9389738
[TBL] [Abstract][Full Text] [Related]
15. Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer.
Hachim IY; Hachim MY; Lopez VM; Lebrun JJ; Ali S
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):238-45. PubMed ID: 26317306
[TBL] [Abstract][Full Text] [Related]
16. The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.
Bachelot A; Carré N; Mialon O; Matelot M; Servel N; Monget P; Ahtiainen P; Huhtaniemi I; Binart N
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E845-52. PubMed ID: 23921141
[TBL] [Abstract][Full Text] [Related]
17. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
Hachim IY; Shams A; Lebrun JJ; Ali S
Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
[TBL] [Abstract][Full Text] [Related]
18. Residue 146 regulates prolactin receptor folding, basal activity and ligand-responsiveness: potential implications in breast tumorigenesis.
Zhang C; Cherifi I; Nygaard M; Haxholm GW; Bogorad RL; Bernadet M; England P; Broutin I; Kragelund BB; Guidotti JE; Goffin V
Mol Cell Endocrinol; 2015 Feb; 401():173-88. PubMed ID: 25524456
[TBL] [Abstract][Full Text] [Related]
19. Could prolactin receptor gene polymorphism play a role in pathogenesis of breast carcinoma?
Canbay E; Degerli N; Gulluoglu BM; Kaya H; Sen M; Bardakci F
Curr Med Res Opin; 2004 Apr; 20(4):533-40. PubMed ID: 15119991
[TBL] [Abstract][Full Text] [Related]
20. Prolactin (PRL) receptor gene expression in mouse adipose tissue: increases during lactation and in PRL-transgenic mice.
Ling C; Hellgren G; Gebre-Medhin M; Dillner K; Wennbo H; Carlsson B; Billig H
Endocrinology; 2000 Oct; 141(10):3564-72. PubMed ID: 11014209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
